Health Care & Life Sciences » Biotechnology | Pluristem Therapeutics Inc.

Pluristem Therapeutics Inc. | Mutual Funds

Mutual Funds that own Pluristem Therapeutics Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
ARK Genomic Revolution Multi Sector ETF
2,172,934
1.96%
12,132
0.94%
09/05/2018
428,106
0.39%
0
2.39%
09/05/2018
142,991
0.13%
0
0.36%
09/06/2018
134,804
0.12%
0
0.14%
05/31/2018
Fidelity Nasdaq Composite Index
109,370
0.1%
0
0%
07/31/2018
83,419
0.08%
-27,775
1.9%
06/28/2018
Maor Luski Selected Shares
79,374
0.07%
5,769
2.31%
05/31/2018
76,000
0.07%
36,500
2.29%
05/31/2018
Psagot Israeli Small Cap
75,213
0.07%
0
0.25%
06/28/2018
Harel Pia Tel - Tec
73,000
0.07%
35,000
1.06%
05/31/2018

About Pluristem Therapeutics

View Profile
Address
MATAM Advanced Technology Park
Haifa HA 31905
Israel
Employees -
Website http://www.pluristem.com
Updated 07/08/2019
Pluristem Therapeutics, Inc. is a biotechnology company, which engages in the provision of cell therapy development. It develops placenta-based cell therapy product candidates for the treatment of multiple ischemic, inflammatory and hematologic conditions. The company focuses on cell therapies for the treatment of diseases such as muscle injury, acute radiation syndrome, pulmonary arterial hypertension and others.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.